Cargando…

Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer

PURPOSE: Circulating tumor DNA (ctDNA) is emerging as a valuable non-invasive tool to identify tumor heterogeneity and tumor burden. This study investigated ctDNA dynamics in metastatic colorectal cancer patients treated with regorafenib. MATERIALS AND METHODS: In this prospective biomarker study, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dae-Won, Lim, Yoojoo, Kim, Hwang-Phill, Kim, Su Yeon, Roh, Hanseong, Kang, Jun-Kyu, Lee, Kyung-Hun, Kim, Min Jung, Ryoo, Seung-Bum, Park, Ji Won, Jeong, Seung-Yong, Park, Kyu Joo, Kang, Gyeong Hoon, Han, Sae-Won, Kim, Tae-You
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372591/ https://www.ncbi.nlm.nih.gov/pubmed/36915247 http://dx.doi.org/10.4143/crt.2023.268

Ejemplares similares

Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer
por: Lim, Yoojoo, et al.
Publicado: (2015)

Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR
por: Lim, Yoojoo, et al.
Publicado: (2021)

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer
por: Ryoo, Seung-Bum, et al.
Publicado: (2023)

FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro
por: Cha, Yongjun, et al.
Publicado: (2018)

Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
por: Yoon, Sang Eun, et al.
Publicado: (2018)

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2015)

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer
por: Yoon, Sang Eun, et al.
Publicado: (2019)

Role of Dedicated Subspecialized Radiologists in Multidisciplinary Team Discussions on Lower Gastrointestinal Tract Cancers
por: Jeon, Sun Kyung, et al.
Publicado: (2022)

RNA editing in RHOQ promotes invasion potential in colorectal cancer
por: Han, Sae-Won, et al.
Publicado: (2014)

Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing
por: Kang, Jun-Kyu, et al.
Publicado: (2020)

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
por: Lee, Dae-Won, et al.
Publicado: (2019)

Whole-Genome Sequence of Mycobacterium tuberculosis Korean Strain KIT87190
por: Park, Young Kil, et al.
Publicado: (2014)

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
por: Park, Hye Eun, et al.
Publicado: (2021)

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
por: Cha, Yongjun, et al.
Publicado: (2016)

Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
por: Han, Sae-Won, et al.
Publicado: (2013)

Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial
por: Kim, Min Jung, et al.
Publicado: (2023)

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”
por: Bae, Jeong Mo, et al.
Publicado: (2018)

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
por: Bae, Jeong Mo, et al.
Publicado: (2017)

Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution
por: Kim, Min Jung, et al.
Publicado: (2019)

Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Kim, Eunji, et al.
Publicado: (2019)

Effects of a Mobile Educational Program for Colorectal Cancer Patients Undergoing the Enhanced Recovery After Surgery
por: Kim, Bo-Yeoul, et al.
Publicado: (2018)

Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer
por: Huh, Ji-Won, et al.
Publicado: (2022)

Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection: A propensity score-matched analysis and meta-analysis
por: Kim, Min Jung, et al.
Publicado: (2016)

Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer
por: Lee, Si-Hyun, et al.
Publicado: (2017)

Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA
por: Yoon, Jung-Ki, et al.
Publicado: (2023)

Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer
por: Kim, Jeong-ki, et al.
Publicado: (2022)

Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells
por: Cheon, Seul‐Ki, et al.
Publicado: (2018)

Two dominant patterns of low anterior resection syndrome and their effects on patients’ quality of life
por: Kim, Min Jung, et al.
Publicado: (2021)

A Novel Scoring System for Response of Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer Using Early-Treatment Blood Features Derived From Machine Learning
por: Kim, Jaesik, et al.
Publicado: (2021)

Laparoscopic versus open lateral pelvic lymph node dissection in locally advanced rectal cancer: multicentre retrospective cohort study
por: Lim, Han-Ki, et al.
Publicado: (2022)

Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment
por: Lee, Min-Sang, et al.
Publicado: (2020)

High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer
por: Lee, Seung Eun, et al.
Publicado: (2019)

Inflammatory Myofibroblastic Tumor of the Retroperitoneum Including Chronic Granulomatous Inflammation Suggesting Tuberculosis: A Case Report
por: Kim, Younglim, et al.
Publicado: (2019)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Safety of temporary ileostomy via specimen extraction site in rectal cancer patients who underwent laparoscopic low anterior resection
por: Lee, Kil-yong, et al.
Publicado: (2019)

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
por: Kim, Youjin, et al.
Publicado: (2019)

D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy
por: Go, Se-Il, et al.
Publicado: (2015)

Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line
por: Lee, Yong Yook, et al.
Publicado: (2013)

Gut microbiome associated with low anterior resection syndrome after rectal cancer surgery
por: Kim, Min Jung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2rvlm5jk01kf4j4ovd6l2f07e4